Non-dihydropyridine calcium channel antagonists in rate control in atrial fibrillation (AF)
Non-dihydropyridine calcium channel antagonists in control of rate in atrial fibrillation (1)
Usual oral maintenance dose | |
verapamil | 40 mg b.i.d. to 360 mg (ER) o.d. |
diltiazem | 60 mg t.i.d. to 360 mg (ER) o.d. |
ER = extended release formulations
Reference:
- (1) Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Guidelines for the management of atrial fibrillation. European Heart Journal (2010) 31, 2369-2429.
Related pages
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page